Pancreatic Cancer Was Controlled In 90% Of Patients In Trial
4 Articles
4 Articles
New Pancreatic Cancer Treatment Stops Tumor Growth in 90% of Patients During Clinical Trial
A targeted cancer drug combined with chemotherapy produced disease control in more than 90% of patients with advanced pancreatic cancer, with researchers reporting substantial tumor ... The post New Pancreatic Cancer Treatment Stops Tumor Growth in 90% of Patients During Clinical Trial first appeared on [your]NEWS.
Progress in the treatment of pancreatic cancer: Daraxonrasib has kept the disease under control in 90% of patients in a study A treatment combining a daily pill called daraxonrasib with chemotherapy has achieved promising results in patients with advanced pancreatic cancer. In a clinical study conducted in 61 people, the disease has been kept under control in 90.2% of participants, and more than 60% of tumors have significantly decreased or beco…
sensational news: a new treatment against pancreatic cancer managed to make the tumors disappear from the examinations of five patients and reduce their size in dozens of others. The results, released this week, show that the combination of a daily tablet with chemotherapy managed to control the disease in 90.2% of the participants in a clinical study. [...]
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium

![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)


